LivaNova has been granted a patent for a system that warms or cools blood in extracorporeal circulation. The system includes an oxygenator with a heat exchanger and a heater/cooler with Peltier elements for cooling and a separate heater for warming, connected by a thermal element. GlobalData’s report on LivaNova gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights LivaNova Plc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on LivaNova, Wearable defibrillators was a key innovation area identified from patents. LivaNova's grant share as of February 2024 was 67%. Grant share is based on the ratio of number of grants to total number of patents.

System for extracorporeal blood circulation with peltier cooler

Source: United States Patent and Trademark Office (USPTO). Credit: LivaNova Plc

A recently granted patent (Publication Number: US11925738B2) discloses a system for extracorporeal blood circulation that includes an oxygenator with a heat exchanger for warming or cooling blood in a patient's circulation. The system also features a heater/cooler with Peltier elements exclusively involved in cooling, along with a separate heater for heat exchange. The heater/cooler is connected to the heat exchanger by a thermal connecting element, ensuring efficient heat transfer within the system.

Moreover, the system includes a reservoir for storing a heat exchanging medium connected to the heat exchanger. The heater/cooler, comprising Peltier elements for cooling and a separate heater, is positioned outside the reservoir and is responsible for heating or cooling the stored medium. The system is versatile and can be utilized in various medical devices like heart-lung machines, extracorporeal membrane oxygenation (ECMO) devices, or minimized extracorporeal circulation (MECC) devices, showcasing its adaptability and potential impact in the field of extracorporeal blood circulation.

To know more about GlobalData’s detailed insights on LivaNova, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.